Latest News about ABBV
Recent news which mentions ABBV
3 Dividend Stocks to Buy In October and Hold Forever
October 05, 2022
From Motley Fool
3 Cheap Stocks to Buy for Their High Cash Flow and Dividends
October 04, 2022
From InvestorPlace
Best Stocks 2022: These 3 Factors Can Send Sonic Automotive (SAH) Stock Soaring in Q4
October 04, 2022
From InvestorPlace
War over drug-cost assistance traps sickest patients in the middle
October 03, 2022
From MarketWatch
Bear Market Bargains: 3 Dividend Stocks to Buy Now
October 03, 2022
From Motley Fool
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
October 02, 2022
From Motley Fool
Here's Why This Dividend King Is a Buy
October 01, 2022
From Motley Fool
Tilray To Crater Over 30%? Here Are 5 Other Price Target Changes For Friday
September 30, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Where to Invest $10,000 Right Now
September 28, 2022
From Motley Fool
2 High-Yielding Dividend Stocks That Could Raise Their Payouts in October
September 27, 2022
From Motley Fool
Is Loading Up on Passive Income Stocks Right Now a Good Idea?
September 27, 2022
From Motley Fool
3 Dividend Aristocrats In Warren Buffett's Secret Portfolio You Can Buy Right Now
September 25, 2022
From Motley Fool
Biden Announces $1.5B To Combat US Overdose Epidemic, Support Recovery
September 23, 2022
From Benzinga
Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond
September 23, 2022
From Motley Fool
Use These 3 Simple Tricks to Maximize Your Returns From AbbVie Stock
September 23, 2022
Tickers
ABBV
From Motley Fool
3 Dividend Stocks You Can Safely Hold for Decades
September 22, 2022
From Motley Fool
Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?
September 22, 2022
From Motley Fool
2 Dividend Stocks to Double Up On Right Now
September 20, 2022
From Motley Fool
3 Passive-Income Stock Secrets You'll Wish You Knew Earlier
September 19, 2022
From Motley Fool
European Authority Backs AbbVie's Crohn's Disease Candidate
September 19, 2022
Tickers
ABBV
From Benzinga
4 Strategies to Try if You Need Extra Cash From Your Investments
September 19, 2022
From Motley Fool
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.